Navigation Links
Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
Date:3/1/2012

On March 9, the New York Academy of Sciences will present "Scientific Considerations for Complex Drugs in Light of Established Regulatory Guidance." This full-day conference will explore current definitions, global scientific and regulatory hurdles, and future challenges for follow-on versions of complex drugs.

On February 9, 2012, the FDA released its much-anticipated new draft guidelines for implementing the Biologics Price Competition and Innovation Act of 2009, which called for an abbreviated approval pathway for biological products that are demonstrated to be "highly similar" to, or "interchangeable" with, a previously approved and regulated drug. However, current U.S. regulations do not make scientific distinctions between small-molecule drugs and non-biological complex drugs; although the latter may present many of the same scientific and clinical challenges to reproduce as biologics.

In light of the recently drafted approval guidelines for biosimilars in the U.S., and increased international concern for new follow-on biological and non-biological products currently defined as "interchangeable" in both established and emerging markets abroad, the Academy will bring together experts representing a variety of perspectives, including industry, regulatory agencies, physicians, and consumers. Representation from the FDA will provide an overview of the demonstration of therapeutic equivalence of complex drug products, which shall inform the day's broader discussions about the regulation of non-biological complex drugs.

Plenary sessions will address the most recent regulatory developments and experimental design, interchangeability, and immunogenicity issues for follow-on versions of complex drugs; featuring conversations led by Larry Lee, PhD, FDA; Ivana Knezevic, MD, PhD, World Health Organization; Huub Schellekens, MD, PhD, Utrecht University; Janet S. Wyatt, PhD, RN, FAANP, Institute of Pediatric Nursing and Arthritis Foundation; Jan
'/>"/>

Contact: Melinda Miller
mmiller@nyas.org
New York Academy of Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Newly-discovered mechanism can explain the Beckwith-Wiedemann syndrome
2. Newly identified gene powerful predictor of colon cancer metastasis
3. Newly found enzymes may play early role in cancer
4. Obesity starts in the head? 6 newly discovered genes for obesity have a neural effect
5. UC Davis research shows that newly discovered drug reduces heart enlargement
6. Newly described contaminant sources in Katrina-flooded homes pose health risks
7. DNA evidence is in, newly discovered species of fish dubbed H. psychedelica
8. Newly discovered gene plays vital role in cancer
9. Newly discovered epidermal growth factor receptor active in human pancreatic cancers
10. Newly discovered reactions from an old drug may lead to new antibiotics
11. Newly discovered snow roots are evolutionary phenomenon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Energy production systems are good examples of complex ... like a networkincluding water for cooling, transport to ... management. Every step in the network chain is ... all mutually dependent. A team of UK-based scientists ... previously explored. The findings have been published in ...
(Date:8/28/2014)... 28, 2014 Dyslexia, the most commonly diagnosed ... neurological reading disability that occurs when the regions ... function normally. , The use of non-invasive functional ... is disrupted in dyslexia. However, most prior work ... brain regions, leaving a gap in our understanding ...
(Date:8/28/2014)... This news release is available in German . ... electronic products are now built with the help of sophisticated ... are fixed, are an important part of these assembly lines. ... are attached in various work stages arranged in a precise ... the end of the line. , The creation of such ...
Breaking Biology News(10 mins):Inter-dependent networks stress test 2Dyslexic readers have disrupted network connections in the brain 2Nanoscale assembly line 2Nanoscale assembly line 3
... and neck cancer in the United States this year and ... published this week in the journal Carcinogenesis shows ... extract (GSE) kills head and neck squamous cell carcinoma cells, ... effect," says Rajesh Agarwal, PhD, investigator at the University of ...
... Cancer is one of the most common causes of ... radiotherapy, chemotherapy, and targeting therapies, which are intended to ... fail, resulting in tumor metastasis and recurrence. Therefore, there ... recent years, an increasing number of studies have revealed ...
... Cell Press reinforces its commitment to provide a broad ... the inaugural issue of a new open-access journal: Cell ... months of hard work on the part of our authors, ... editorial and production teams, the first issue is available online ...
Cached Biology News:Immunological mechanisms of oncolytic adenoviral therapy 2Immunological mechanisms of oncolytic adenoviral therapy 3Cell Press launches a new open-access journal, Cell Reports 2
(Date:8/28/2014)... Best Sanitizers, Inc., the first company ... sanitizer, asks food processors and food handling professionals to ... they’re currently using to Best Sanitizers’ Alpet® E3 ... to fighting cross-contamination and the spread of pathogens in ... are key criteria that make a hand sanitizer most ...
(Date:8/28/2014)... converters are important devices in spintronics, an electronic ... of electrons but also on their spin and ... of electric into magnetic signals and vice versa. ... from the Institute of Physics at Johannes Gutenberg ... UK, Prague, and Japan, has for the first ...
(Date:8/28/2014)... month, executives from clinical trial marketing firm BBK Worldwide will ... Patient-Centered Clinical Trials 2014 , to be held at the ... 4-5. Patient recruitment experts Bonnie A. Brescia , ... insights on the benefits of employing an effective patient engagement ... to mobile apps – can be used to drive study ...
(Date:8/28/2014)... , Aug. 28, 2014  Armetheon, Inc. ... developing novel mid- to late-stage cardiovascular drug candidates, ... in its first round of financing. The Series ... and Hercules Bioventures with participation from investors that ... pharmaceutical executive, Dr. Larry Hsu , the ...
Breaking Biology Technology:Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3A new, tunable device for spintronics 2A new, tunable device for spintronics 3BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... David H. Murdock Research Institute (DHMRI) today announced the ... a next step in the continued growth of the ... Kannapolis, NC. Driven by a mission to accelerate the ... of immune-related diseases, the DHMRI provides integrated, state-of-the-art genomic, ...
... energy-guru and favourite read of Bill Gates, Vaclav Smil,s gloomy ... Raynolds. "You need a hug," Raynolds said. ... took place on TVO,s The Agenda with Steve Paikan live ... is now archived at http://wgsi.org/events/tvos-agenda-steve-paikin-1 . THE ...
... June 8, 2011 Northwest Biotherapeutics (OTC.BB: NWBO) today ... its management team, adding several highly experienced executives.  Ms. ... Board since May 2007, has been appointed Chief Executive ... in the field of cancer immune therapies, is joining ...
Cached Biology Technology:David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development 2David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development 3High voltage! Power experts pull out all the stops at international energy meeting 2Northwest Biotherapeutics Announces Change and Expansion of Management Team 2Northwest Biotherapeutics Announces Change and Expansion of Management Team 3Northwest Biotherapeutics Announces Change and Expansion of Management Team 4Northwest Biotherapeutics Announces Change and Expansion of Management Team 5Northwest Biotherapeutics Announces Change and Expansion of Management Team 6
... microarray data using Asuragens bioinformatics expertise. We ... to extensive data analysis using the most ... in combination with the Gene Expression Profiling ... ,Normalization and basic statistical analysis including publication ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
... Maximize the value of your microarray ... the support you need from consultation to ... to date methods. Utilize our expertise in ... or from your own microarray experiments., ,Normalization ...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
Biology Products: